VC
MJN

V2 Capital’s Mead Johnson Nutrition Company MJN Stock Holding History

V2 Capital’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$5.42M Buy
+53,870
New +$5.43M 2.25% 14

Other funds holding MJN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

V2 Capital's MJN Position: Q1 2015 in Review

V2 Capital opened a new position in Mead Johnson Nutrition Company (MJN) in Q1 2015: 53,870 shares worth $5.42M. The stake represents 2.25% of the portfolio and ranks #14 among its holdings.

547 funds tracked by Wall St. Rank hold MJN as of Q1 2015.

  • V2 Capital held 53,870 shares of Mead Johnson Nutrition Company worth $5.42M as of Q1 2015.
  • Mead Johnson Nutrition Company was a new V2 Capital position in Q1 2015.
  • Mead Johnson Nutrition Company made up 2.25% of V2 Capital's portfolio in Q1 2015, its #14 holding.
  • 547 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2015.

Based on V2 Capital's 13F filing for Q1 2015, filed 5 May 2015.